234 related articles for article (PubMed ID: 26678309)
41. Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway.
Hur W; Lee JH; Kim SW; Kim JH; Bae SH; Kim M; Hwang D; Kim YS; Park T; Um SJ; Song BJ; Yoon SK
Int J Biochem Cell Biol; 2015 Jul; 64():265-76. PubMed ID: 25957914
[TBL] [Abstract][Full Text] [Related]
42. The NOX1 isoform of NADPH oxidase is involved in dysfunction of liver sinusoids in nonalcoholic fatty liver disease.
Matsumoto M; Zhang J; Zhang X; Liu J; Jiang JX; Yamaguchi K; Taruno A; Katsuyama M; Iwata K; Ibi M; Cui W; Matsuno K; Marunaka Y; Itoh Y; Torok NJ; Yabe-Nishimura C
Free Radic Biol Med; 2018 Feb; 115():412-420. PubMed ID: 29274380
[TBL] [Abstract][Full Text] [Related]
43. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.
Maximos M; Bril F; Portillo Sanchez P; Lomonaco R; Orsak B; Biernacki D; Suman A; Weber M; Cusi K
Hepatology; 2015 Jan; 61(1):153-60. PubMed ID: 25145475
[TBL] [Abstract][Full Text] [Related]
44. Ablation of eNOS does not promote adipose tissue inflammation.
Jurrissen TJ; Sheldon RD; Gastecki ML; Woodford ML; Zidon TM; Rector RS; Vieira-Potter VJ; Padilla J
Am J Physiol Regul Integr Comp Physiol; 2016 Apr; 310(8):R744-51. PubMed ID: 26864812
[TBL] [Abstract][Full Text] [Related]
45. Critical Role for Hepatocyte-Specific eNOS in NAFLD and NASH.
Cunningham RP; Moore MP; Dashek RJ; Meers GM; Takahashi T; Sheldon RD; Wheeler AA; Diaz-Arias A; Ibdah JA; Parks EJ; Thyfault JP; Rector RS
Diabetes; 2021 Nov; 70(11):2476-2491. PubMed ID: 34380696
[TBL] [Abstract][Full Text] [Related]
46. Hepatic expression of the Sptlc3 subunit of serine palmitoyltransferase is associated with the development of hepatocellular carcinoma in a mouse model of nonalcoholic steatohepatitis.
Yoshimine Y; Uto H; Kumagai K; Mawatari S; Arima S; Ibusuki R; Mera K; Nosaki T; Kanmura S; Numata M; Tamai T; Moriuchi A; Tsubouchi H; Ido A
Oncol Rep; 2015 Apr; 33(4):1657-66. PubMed ID: 25607821
[TBL] [Abstract][Full Text] [Related]
47. The inhibitory effect of black soybean on hepatic cholesterol accumulation in high cholesterol and high fat diet-induced non-alcoholic fatty liver disease.
Jung JH; Kim HS
Food Chem Toxicol; 2013 Oct; 60():404-12. PubMed ID: 23900008
[TBL] [Abstract][Full Text] [Related]
48. Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor α in mice.
Zhu LH; Wang A; Luo P; Wang X; Jiang DS; Deng W; Zhang X; Wang T; Liu Y; Gao L; Zhang S; Zhang X; Zhang J; Li H
J Hepatol; 2014 May; 60(5):1046-54. PubMed ID: 24445216
[TBL] [Abstract][Full Text] [Related]
49. TNFα gene knockout differentially affects lipid deposition in liver and skeletal muscle of high-fat-diet mice.
Salles J; Tardif N; Landrier JF; Mothe-Satney I; Guillet C; Boue-Vaysse C; Combaret L; Giraudet C; Patrac V; Bertrand-Michel J; Denis P; Chardigny JM; Boirie Y; Walrand S
J Nutr Biochem; 2012 Dec; 23(12):1685-93. PubMed ID: 22464148
[TBL] [Abstract][Full Text] [Related]
50. Hepatocyte specific deletion of c-Met leads to the development of severe non-alcoholic steatohepatitis in mice.
Kroy DC; Schumacher F; Ramadori P; Hatting M; Bergheim I; Gassler N; Boekschoten MV; Müller M; Streetz KL; Trautwein C
J Hepatol; 2014 Oct; 61(4):883-90. PubMed ID: 24845607
[TBL] [Abstract][Full Text] [Related]
51. Impairment of endothelial nitric oxide synthase causes abnormal fat and glycogen deposition in liver.
Schild L; Dombrowski F; Lendeckel U; Schulz C; Gardemann A; Keilhoff G
Biochim Biophys Acta; 2008 Mar; 1782(3):180-7. PubMed ID: 18206129
[TBL] [Abstract][Full Text] [Related]
52. Early steatohepatitis in hyperlipidemic mice with endothelial-specific gain of TRPC3 function precedes changes in aortic atherosclerosis.
Smedlund K; Dube P; Vazquez G
Physiol Genomics; 2016 Aug; 48(8):644-9. PubMed ID: 27449657
[TBL] [Abstract][Full Text] [Related]
53. Heterozygous midnolin knockout attenuates severity of nonalcoholic fatty liver disease in mice fed a Western-style diet high in fat, cholesterol, and fructose.
Kweon SM; Irimia-Dominguez J; Kim G; Fueger PT; Asahina K; Lai KK; Allende DS; Lai QR; Lou CH; Tsark WM; Yang JD; Ng DS; Lee JS; Tso P; Huang W; Lai KKY
Am J Physiol Gastrointest Liver Physiol; 2023 Aug; 325(2):G147-G157. PubMed ID: 37129245
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of high-fat high-fructose diet treatment in factor VIII (coagulation factor)-deficient mouse model.
Mishra A; Arindkar S; Sahay P; Kumar JM; Upadhyay PK; Majumdar SS; Nagarajan P
Int J Exp Pathol; 2018 Feb; 99(1):46-53. PubMed ID: 29656466
[TBL] [Abstract][Full Text] [Related]
55. Involvement of microsomal triglyceride transfer protein in nonalcoholic steatohepatitis in novel spontaneous mouse model.
Shindo N; Fujisawa T; Sugimoto K; Nojima K; Oze-Fukai A; Yoshikawa Y; Wang X; Yasuda O; Ikegami H; Rakugi H
J Hepatol; 2010 Jun; 52(6):903-12. PubMed ID: 20392512
[TBL] [Abstract][Full Text] [Related]
56. Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation.
Andrade JM; Paraíso AF; de Oliveira MV; Martins AM; Neto JF; Guimarães AL; de Paula AM; Qureshi M; Santos SH
Nutrition; 2014; 30(7-8):915-9. PubMed ID: 24985011
[TBL] [Abstract][Full Text] [Related]
57. Metformin prevents liver tumorigenesis induced by high-fat diet in C57Bl/6 mice.
Tajima K; Nakamura A; Shirakawa J; Togashi Y; Orime K; Sato K; Inoue H; Kaji M; Sakamoto E; Ito Y; Aoki K; Nagashima Y; Atsumi T; Terauchi Y
Am J Physiol Endocrinol Metab; 2013 Oct; 305(8):E987-98. PubMed ID: 23964070
[TBL] [Abstract][Full Text] [Related]
58. Dietary glycotoxins exacerbate progression of experimental fatty liver disease.
Leung C; Herath CB; Jia Z; Goodwin M; Mak KY; Watt MJ; Forbes JM; Angus PW
J Hepatol; 2014 Apr; 60(4):832-8. PubMed ID: 24316518
[TBL] [Abstract][Full Text] [Related]
59. Celastrus orbiculatus Thunb. ameliorates high-fat diet-induced non-alcoholic fatty liver disease in guinea pigs.
Zhang Y; Si Y; Zhai L; Yang N; Yao S; Sang H; Zu D; Xu X; Qin S; Wang J
Pharmazie; 2013 Oct; 68(10):850-4. PubMed ID: 24273892
[TBL] [Abstract][Full Text] [Related]
60. Troxerutin improves hepatic lipid homeostasis by restoring NAD(+)-depletion-mediated dysfunction of lipin 1 signaling in high-fat diet-treated mice.
Zhang ZF; Fan SH; Zheng YL; Lu J; Wu DM; Shan Q; Hu B
Biochem Pharmacol; 2014 Sep; 91(1):74-86. PubMed ID: 25026599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
